middle.news
Island Pharmaceuticals Strengthens US Biodefence Ties Ahead of Galidesivir Trials
8:44am on Tuesday 19th of May, 2026 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Strengthens US Biodefence Ties Ahead of Galidesivir Trials
8:44am on Tuesday 19th of May, 2026 AEST
Key Points
Appointment of Mark Herzog enhances US biodefence engagement
Secured positions on Medical Countermeasures Coalition working groups
Advancing Galidesivir development under FDA Animal Rule
Ongoing negotiations for US BSL-4 trial facilities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE